Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

EV 68228 N

Drug Profile

EV 68228 N

Alternative Names: Enterovirus D68-specific monoclonal antibody - KBio; EV68-228-N; EVD68-228N; KB-13-A

Latest Information Update: 03 Jul 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator KBio
  • Developer KBio; National Institute of Allergy and Infectious Diseases
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action Capsid protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Enterovirus infections
  • Preclinical Acute flaccid myelitis

Most Recent Events

  • 28 Jun 2024 US FDA approves IND application for EV 68228 N in Acute flaccid myelitis
  • 11 Jun 2024 Phase-I clinical trials in Enterovirus infections (In volunteers) in USA (IV) (NCT06444048)
  • 05 Jun 2024 EV 68228 N is available for licensing as of 05 Jun 2024. https://kbio.com/
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top